about
Angiotensin II-induced sudden arrhythmic death and electrical remodelingImportance of CXC chemokine receptor 2 in the homing of human peripheral blood endothelial progenitor cells to sites of arterial injuryCX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survivalY-box binding protein-1 controls CC chemokine ligand-5 (CCL5) expression in smooth muscle cells and contributes to neointima formation in atherosclerosis-prone miceNovel role for inhibitor of differentiation 2 in the genesis of angiotensin II-induced hypertensionChemokines in atherosclerosis: an update.Immunosuppressive treatment protects against angiotensin II-induced renal damageAldosterone, mineralocorticoid receptors, and vascular inflammation.A peroxisome proliferator-activated receptor-alpha activator induces renal CYP2C23 activity and protects from angiotensin II-induced renal injury.High expression of C5L2 correlates with high proinflammatory cytokine expression in advanced human atherosclerotic plaques.Importance of junctional adhesion molecule-C for neointimal hyperplasia and monocyte recruitment in atherosclerosis-prone mice-brief report.P450-dependent arachidonic acid metabolism and angiotensin II-induced renal damage.Cardiac hypertrophy and fibrosis in chronic L-NAME-treated AT2 receptor-deficient mice.Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells.Inducible NOS inhibition, eicosapentaenoic acid supplementation, and angiotensin II-induced renal damage.Cardiac gene expression profile in rats with terminal heart failure and cachexia.Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage.Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in double-transgenic rats.Complement activation in angiotensin II-induced organ damage.C1-esterase inhibitor protects against neointima formation after arterial injury in atherosclerosis-prone mice.Complement C5a receptors C5L2 and C5aR in renal fibrosis.Endothelial CSN5 impairs NF-κB activation and monocyte adhesion to endothelial cells and is highly expressed in human atherosclerotic lesions.Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis.Nf-kappab and AP-1 activation is associated with late lumen loss after porcine coronary angioplasty and antiproliferative beta-irradiation.p38 mitogen-activated protein kinase inhibition ameliorates angiotensin II-induced target organ damage.Agonistic autoantibodies to the AT1 receptor in a transgenic rat model of preeclampsia.Atheroprotective role of C5ar2 deficiency in apolipoprotein E-deficient mice.Deficiency of endothelial CXCR4 reduces reendothelialization and enhances neointimal hyperplasia after vascular injury in atherosclerosis-prone mice.C5a receptor targeting in neointima formation after arterial injury in atherosclerosis-prone mice.Complement activation in vascular remodeling and organ damageLow-dose renin inhibitor and low-dose AT1-receptor blocker therapy ameliorate target-organ damage in rats harbouring human renin and angiotensinogen genesHematopoietic Interferon Regulatory Factor 8-Deficiency Accelerates Atherosclerosis in Mice
P50
Q24302066-1948A607-6A83-4E93-A523-5C040548CCBDQ28286412-F5C27847-A553-4765-A0C7-3346E89757F5Q28506756-1AA928C9-1538-4609-857F-68A34FC4B852Q28579311-AEB7089E-98F1-4B07-880F-26FA3D2D9297Q28588916-99A75CE5-14DA-48AB-9E5C-CF8D06176F10Q34656531-30377363-2C45-49FE-BF12-4B621C228ADFQ35747734-4DDB6E9E-8068-4FBA-83D8-1C96DC52AFFAQ36733555-AFA73B27-1B0F-4A23-B07F-4C1E3E1D6CA5Q38584663-A9F132E6-DC38-4B72-84F2-AD01AF637770Q39193960-2F456233-47CE-4CBE-BFB5-8411206145EBQ43567428-2616B24C-B026-4F5D-A041-A8612B47E929Q44127994-68A41370-05D6-41A1-8CD0-016273B741AFQ44851453-B4E0F1C1-91B1-42B0-8180-9AAEDBA52E44Q44907744-A65875F8-0926-4D46-8943-55FD7F3633BFQ45195079-D8FF6167-BAE5-4FFF-A433-D1EE9B91C6C6Q45205031-3A92DF22-A0BB-4236-BC04-B9DE04F2983EQ46531368-E109F28C-45FD-4F31-8310-61D2BF9C0EE3Q46652759-79C3ADEF-FBBB-4BEB-A9D7-756C738D3635Q46658434-4651578B-0CCE-434D-9937-268A86C9EA2CQ46856886-0BB47FFB-AE55-49A4-B528-2455A9198A2EQ48352166-4D0DDC32-4EAE-413A-BB33-B73C863A34D3Q51026243-7E329763-EC4A-4767-A110-1CB7E9198907Q52583321-42FF8159-959C-4B84-AFA4-8F31C515BF7BQ52926539-94F30C7B-7E00-4A59-B396-7F62F353C610Q52927963-F41BA0FE-EA99-43C9-A854-5373DB9328D0Q52940276-96BAB613-73B5-419B-9F74-B41524806634Q53464441-18CB3DBF-4A6B-47EB-8026-348E56F8D4F8Q54360753-2E8DBE40-AD6C-4FD3-A056-BE235F703F1CQ54414303-2ED0F160-DD6D-405E-B710-7B2F2B93147CQ56985230-8EFDF360-8563-41A8-AD50-639D5E88D747Q56985246-DCB2ACE8-59DF-48BD-8744-A91433AB2748Q57574582-FFEE84AC-6933-4E84-9F4B-C5EFF298FFA1
P50
name
Erdenechimeg Shagdarsuren
@ast
Erdenechimeg Shagdarsuren
@en
Erdenechimeg Shagdarsuren
@nl
type
label
Erdenechimeg Shagdarsuren
@ast
Erdenechimeg Shagdarsuren
@en
Erdenechimeg Shagdarsuren
@nl
prefLabel
Erdenechimeg Shagdarsuren
@ast
Erdenechimeg Shagdarsuren
@en
Erdenechimeg Shagdarsuren
@nl